We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$23.1B
1-Year Est. Return
49.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+49.74%
3 Year Est. Return
+142.09%
5 Year Est. Return
+159.34%
10 Year Est. Return
–
AUM
$16.2B
AUM Growth
-$2.2B
(-12%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
198
New
16
Increased
100
Reduced
56
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$255M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$202M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$174M |
| 4 |
Apple
AAPL
|
+$167M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$171M |
| 2 |
Veeva Systems
VEEV
|
+$170M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$169M |
| 4 |
VF Corp
VFC
|
+$123M |
| 5 |
Adobe
ADBE
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Materials | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
F5
FFIV
$22.2B
| $19.8M | 0.12% |
129,294
+22,269
| +21% | +$3.87M |
|
127
Cardinal Health
CAH
$57.8B
| $19.8M | 0.12% |
378,392
-259,472
| -41% | -$14.7M |
|
128
Western Union
WU
$2.26B
| $19.8M | 0.12% |
1,199,425
-116,366
| -9% | -$2.05M |
|
129
Restaurant Brands International
QSR
$28B
| $19.6M | 0.12% |
390,815
+124,300
| +47% | +$6.65M |
|
130
Arrow Electronics
ARW
$10.7B
| $19.5M | 0.12% |
173,998
-3,059
| -2% | -$357K |
|
131
UGI
UGI
$8.11B
| $18.9M | 0.12% |
489,802
+214,350
| +78% | +$8.31M |
|
132
American Financial Group
AFG
$12B
| $18.8M | 0.12% |
135,343
+39,546
| +41% | +$5.56M |
|
133
Church & Dwight Co
CHD
$23.4B
| $18.6M | 0.11% |
200,393
+127,654
| +175% | +$12.1M |
|
134
Huntington Ingalls Industries
HII
$11.5B
| $18.4M | 0.11% |
84,273
-34,663
| -29% | -$7.32M |
|
135
Lear
LEA
$6.46B
| $18.3M | 0.11% |
145,428
+26,587
| +22% | +$3.51M |
|
136
CDW
CDW
$19.2B
| $17M | 0.11% |
108,021
+21,034
| +24% | +$3.54M |
|
|
MRSH
137
Marsh
MRSH
$89.9B
| $16.9M | 0.1% |
+109,026
| New | +$17.5M |
|
138
PepsiCo
PEP
$191B
| $16.8M | 0.1% |
100,555
-95,764
| -49% | -$16.1M |
|
139
Merck
MRK
$376B
| $16.8M | 0.1% |
183,802
-444,600
| -71% | -$39.4M |
|
140
Carlyle Group
CG
$17B
| $16.1M | 0.1% |
507,971
+285,831
| +129% | +$11M |
|
141
Annaly Capital Management
NLY
$17.2B
| $16M | 0.1% |
678,018
+134,697
| +25% | +$3.49M |
|
142
Gartner
IT
$12.3B
| $15.6M | 0.1% |
64,377
+6,333
| +11% | +$1.68M |
|
143
U-Haul Holding Co
UHAL
$13.1B
| $15.3M | 0.09% |
319,000
+68,360
| +27% | +$3.53M |
|
144
Molson Coors Class B
TAP
$7.56B
| $15.1M | 0.09% |
276,486
-145,050
| -34% | -$7.79M |
|
145
RPM International
RPM
$13.2B
| $14.9M | 0.09% |
189,276
+89,275
| +89% | +$7.5M |
|
146
Teva Pharmaceuticals
TEVA
$42.7B
| $14.8M | 0.09% |
1,961,747
-702,819
| -26% | -$6.12M |
|
147
SEI Investments
SEIC
$13.4B
| $13.7M | 0.08% |
254,034
+3,710
| +1% | +$209K |
|
|
CTXS
148
DELISTED
Citrix Systems Inc
CTXS
| $13.5M | 0.08% |
139,129
| – | – |
|
149
Diamondback Energy
FANG
$56.8B
| $13.3M | 0.08% |
+109,591
| New | +$15M |
|
150
Apollo Global Management
APO
$79.4B
| $12.6M | 0.08% |
259,335
-9,193
| -3% | -$500K |
|
Similar funds
CLGM
DSA
BBHC
CB
EIM
AustralianSuper's Q2 2022 Portfolio in Review
As of Q2 2022, AustralianSuper held 198 positions worth $16.2B, down 12% from $18.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AustralianSuper deployed $736M of net new capital in Q2 2022, opening 16 new positions and adding to 100 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 387,567 shares worth $192M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Estee Lauder, an estimated $171M trimmed.
- AustralianSuper's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 387,567 shares worth $192M.
- AustralianSuper added most to Intuit in Q2 2022, an estimated $255M increase.
- AustralianSuper's biggest Q2 2022 reduction was Estee Lauder, cutting an estimated $171M.
- AustralianSuper fully exited Goldman Sachs in Q2 2022, selling an estimated $86.5M.
- AustralianSuper's ten largest holdings make up 35% of its $16.2B portfolio in Q2 2022.
- AustralianSuper opened 16 new positions and closed 23 in Q2 2022.
- AustralianSuper's portfolio value fell 12% quarter-over-quarter to $16.2B.
Based on AustralianSuper's 13F filing for Q2 2022, filed 13 Jul 2022.